A genetic association study of CSMD1 and CSMD2 with cognitive function

Brain, Behavior, and Immunity

Volumn 61, Issue , 2017, Pages 209-216

  Athanasiu, Lavinia ^a,b   Giddaluru, Sudheer ^c,d   Fernandes, Carla ^c,d   Christoforou, Andrea ^c,d   Reinvang, Ivar ^b   Lundervold, Astri J ^c,e   Nilsson, Lars Göran ^f,g   Kauppi, Karolina ^f,h   Adolfsson, Rolf ^h   Eriksson, Elias ⁱ   Sundet, Kjetil ^b   Djurovic, Srdjan ^a,b,c   Espeseth, Thomas ^a,b   Nyberg, Lars ^f,h   Steen, Vidar M ^c,d   Andreassen, Ole A ^a,b   Le Hellard, Stephanie ^c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Department of Biological and Medical Psychology ^*  (Norway)

^f UMEÅ UNIVERSITY   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UMEÅ UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cognition; Complement; CSMD1; CSMD2; GWAS; Immunity; Memory; Psychiatry; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CSMD1 GENE; CSMD2 GENE; EPISODIC MEMORY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFORMED CONSENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PHENOTYPE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

CSMD1 PROTEIN, HUMAN; CSMD2 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AGED; COGNITION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 85009442777     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.11.026     Document Type: Article

References (71)

1. Anney, R., Klei, L., Pinto, D., Regan, R., Conroy, J., Magalhaes, T.R., et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19 (2010), 4072–4082.
2. Athanasiu, L., Mattingsdal, M., Kahler, A.K., Brown, A., Gustafsson, O., Agartz, I., et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J. Psychiatr. Res. 44 (2010), 748–753.
3. Ben-David, E., Shohat, S., Shifman, S., Allelic expression analysis in the brain suggests a role for heterogeneous insults affecting epigenetic processes in autism spectrum disorders. Hum. Mol. Genet. 23 (2014), 4111–4124.
4. Bora, E., Yucel, M., Pantelis, C., Cognitive impairment in affective psychoses: a meta-analysis. Schizophr. Bull. 36 (2010), 112–125.
5. Bulik-Sullivan, B., Finucane, H.K., Anttila, V., Gusev, A., Day, F.R., Loh, P.R., et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47 (2015), 1236–1241.
6. Burgner, D., Davila, S., Breunis, W.B., Ng, S.B., Li, Y., Bonnard, C., et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet., 5, 2009, e1000319.
7. Chen, J.A., Penagarikano, O., Belgard, T.G., Swarup, V., Geschwind, D.H., The emerging picture of autism spectrum disorder: genetics and pathology. Annu. Rev. Pathol. 10 (2015), 111–144.
8. Chung, W.S., Welsh, C.A., Barres, B.A., Stevens, B., Do glia drive synaptic and cognitive impairment in disease?. Nat. Neurosci. 18 (2015), 1539–1545.
9. Consortium GT, Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348 (2015), 648–660.
10. Cukier, H.N., Dueker, N.D., Slifer, S.H., Lee, J.M., Whitehead, P.L., Lalanne, E., et al. Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol. Autism, 5, 2014, 1.
11. Davies, G., Armstrong, N., Bis, J.C., Bressler, J., Chouraki, V., Giddaluru, S., et al. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N = 53 949). Mol. Psychiatry 20 (2015), 183–192.
12. Debette, S., Ibrahim Verbaas, C.A., Bressler, J., Schuur, M., Smith, A., Bis, J.C., et al. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Biol. Psychiatry 77 (2015), 749–763.
13. Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., California Verbal Learning Test. 2nd ed., 2000, The Psychological Corporation, San Antonio: TX.
14. Delis, D.C., Kaplan, E., Kramer, J.H., 2001. D-KEFS: Examiners Manual, San Antonio TX.
15. Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., California Verbal Learning Test – Second edition (CVLT-II). Norwegian Manual Supplement. 2004, Pearson Assessment, Stockholm.
16. Delis, D.C., Kaplan, E., Kramer, J.H., Delis – Kaplan Executive Function System (D-KEFS) Norwegian Manual. 2005, Pearson Assessment, Stockholm.
17. Djurovic, S., Gustafsson, O., Mattingsdal, M., Athanasiu, L., Bjella, T., Tesli, M., et al. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J. Affect. Disord. 126 (2010), 312–316.
18. Donohoe, G., Walters, J., Hargreaves, A., Rose, E.J., Morris, D.W., Fahey, C., et al. Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. Genes Brain Behav. 12 (2013), 203–209.
19. Escudero-Esparza, A., Kalchishkova, N., Kurbasic, E., Jiang, W.G., Blom, A.M., The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. FASEB J. 27 (2013), 5083–5093.
20. Espeseth, T., Christoforou, A., Lundervold, A., Steen, V.M., Le Hellard, S., Reinvang, I., Imaging and cognitive genetics: the Norwegian cognitive neurogenetics sample. Twin Res. Hum. Genet. 15 (2012), 442–452.
21. Farrell, C., Crimm, H., Meeh, P., Croshaw, R., Barbar, T., Vandersteenhoven, J.J., et al. Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biol. Ther. 7 (2008), 609–613.
22. Finseth, P.I., Sonderby, I.E., Djurovic, S., Agartz, I., Malt, U.F., Melle, I., et al. Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia. J. Affect. Disord. 163 (2014), 110–114.
23. Giddaluru, S., Espeseth, T., Salami, A., Westlye, L.T., Lundquist, A., Christoforou, A., et al. Genetics of structural connectivity and information processing in the brain. Brain Struct. Funct. 221 (2016), 4643–4661.
24. Hardin, M., Cho, M., McDonald, M.L., Beaty, T., Ramsdell, J., Bhatt, S., et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur. Respir. J. 44 (2014), 341–350.
25. Hashimoto, R., Ikeda, M., Ohi, K., Yasuda, Y., Yamamori, H., Fukumoto, M., et al. Genome-wide association study of cognitive decline in schizophrenia. Am. J. Psychiatry 170 (2013), 683–684.
26. Havik, B., Rokke, H., Dagyte, G., Stavrum, A.K., Bramham, C.R., Steen, V.M., Synaptic activity-induced global gene expression patterns in the dentate gyrus of adult behaving rats: induction of immunity-linked genes. Neuroscience 148 (2007), 925–936.
27. Havik, B., Le Hellard, S., Rietschel, M., Lybaek, H., Djurovic, S., Mattheisen, M., et al. The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol. Psychiatry 70 (2011), 35–42.
28. Hill, W.D., Davies, G., van de Lagemaat, L.N., Christoforou, A., Marioni, R.E., Fernandes, C.P., et al. Human cognitive ability is influenced by genetic variation in components of postsynaptic signalling complexes assembled by NMDA receptors and MAGUK proteins. Transl. Psychiatry, 4, 2014, e341.
29. Hong, S., Beja-Glasser, V.F., Nfonoyim, B.M., Frouin, A., Li, S., Ramakrishnan, S., et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352 (2016), 712–716.
30. Ibrahim-Verbaas, C.A., Bressler, J., Debette, S., Schuur, M., Smith, A.V., Bis, J.C., et al. GWAS for executive function and processing speed suggests involvement of the CADM2 gene. Mol. Psychiatry 21 (2016), 189–197.
31. International Schizophrenia Consortium, Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008), 237–241.
32. Johnson, W., Bouchard, T.J. Jr., Kruger, R.F., McGue, M., Gottesman, I.I., Just one g: consistent results from three test batteries. Intelligence 32 (2004), 95–107.
33. Johnson, W., te Nijenhuis, J., Bouchard, T.J. Jr., Still just 1 g: consistent results from five test batteries. Intelligence 36 (2008), 81–95.
34. Kahn, R.S., Keefe, R.S., Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 70 (2013), 1107–1112.
35. Koiliari, E., Roussos, P., Pasparakis, E., Lencz, T., Malhotra, A., Siever, L.J., et al. The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males. Schizophr. Res. 154 (2014), 42–47.
36. Kraus, D.M., Elliott, G.S., Chute, H., Horan, T., Pfenninger, K.H., Sanford, S.D., et al. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J. Immunol. 176 (2006), 4419–4430.
37. Le Hellard, S., Wang, Y., Witoelar, A., Zuber, V., Bettella, F., Hugdahl, K., et al., in press. Identification of gene loci that overlap between schizophrenia and educational attainment. Schizophr. Bull. PMID: 27338279.
38. Lencz, T., Knowles, E., Davies, G., Guha, S., Liewald, D.C., Starr, J.M., et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol. Psychiatry 19 (2014), 168–174.
39. Li, J., Ji, L., Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95 (2005), 221–227.
40. Li, Y., Willer, C.J., Ding, J., Scheet, P., Abecasis, G.R., MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34 (2010), 816–834.
41. Luksys, G., Fastenrath, M., Coynel, D., Freytag, V., Gschwind, L., Heck, A., et al. Computational dissection of human episodic memory reveals mental process-specific genetic profiles. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), E4939–E4948.
42. Maunakea, A.K., Nagarajan, R.P., Bilenky, M., Ballinger, T.J., D'Souza, C., Fouse, S.D., et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466 (2010), 253–257.
43. McIntosh, A.M., Gow, A., Luciano, M., Davies, G., Liewald, D.C., Harris, S.E., et al. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biol. Psychiatry 73 (2013), 938–943.
44. Meda, S.A., Ruano, G., Windemuth, A., O'Neil, K., Berwise, C., Dunn, S.M., et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), E2066–E22075.
45. Neale, B.M., Sham, P.C., The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75 (2004), 353–362.
46. Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium, Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18 (2015), 199–209.
47. Nilsson, L.G., Bäckman, L., Erngrud, K., Nyberg, L., Adolfsson, R., Bucht, G., et al. The betula prospective cohort study: memory, health, and aging. Aging Neuropsychol. Cogn. 4 (1997), 1–32.
48. Nyholt, D.R., A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74 (2004), 765–769.
49. Pei, Y.F., Zhang, L., Papasian, C.J., Wang, Y.P., Deng, H.W., On individual genome-wide association studies and their meta-analysis. Hum. Genet. 133 (2014), 265–279.
50. Polderman, T.J., Benyamin, B., de Leeuw, C.A., Sullivan, P.F., van Bochoven, A., Visscher, P.M., et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat. Genet. 47 (2015), 702–709.
51. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (2007), 559–575.
52. Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506 (2014), 185–190.
53. Ramasamy, A., Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17 (2014), 1418–1428.
54. Ringman, J.M., Goate, A., Masters, C.L., Cairns, N.J., Danek, A., Graff-Radford, N., et al. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr. Neurol. Neurosci. Rep., 14, 2014, 499.
55. Ripke, S., Sanders, A.R., Kendler, K.S., Levinson, D.F., Sklar, P., Holmans, P.A., et al. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43 (2011), 969–976.
56. Robinson, O.J., Brain burdens: boost resilience to tackle mental illness. Nature, 478, 2011, 459.
57. Schafer, D.P., Lehrman, E.K., Kautzman, A.G., Koyama, R., Mardinly, A.R., Yamasaki, R., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74 (2012), 691–705.
58. Schizophrenia Working Group of the Pyschiatric Genomics Consortium, Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427.
59. Sekar, A., Bialas, A.R., de Rivera, H., Davis, A., Hammond, T.R., Kamitaki, N., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
60. Sherva, R., Wang, Q., Kranzler, H., Zhao, H., Koesterer, R., Herman, A., et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry 73 (2016), 472–480.
61. Simonsen, C., Sundet, K., Vaskinn, A., Birkenaes, A.B., Engh, J.A., Faerden, A., et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr. Bull. 37 (2011), 73–83.
62. Spitzer, R.L., Williams, J.B., Kroenke, K., Linzer, M., deGruy, F.V. 3rd, Hahn, S.R., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272 (1994), 1749–1756.
63. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O.P., Ingason, A., Steinberg, S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008), 232–236.
64. Stephan, A.H., Barres, B.A., Stevens, B., The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35 (2012), 369–389.
65. Toulopoulou, T., Picchioni, M., Rijsdijk, F., Hua-Hall, M., Ettinger, U., Sham, P., et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch. Gen. Psychiatry 64 (2007), 1348–1355.
66. Ward, L.D., Kellis, M., HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 44 (2016), D877–D881.
67. Wechsler, D., Wechsler Abbreviated Scale of Intelligence (WASI). Norwegian Manual Supplement. 2007, Pearson Assessment, Stockholm.
68. Weschler, D., Weschler Adult Scale of Intelligence. 1999, Psychological Corporation, TX.
69. Willer, C.J., Li, Y., Abecasis, G.R., METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26 (2010), 2190–2191.
70. Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21 (2011), 655–679.
71. Xu, W., Cohen-Woods, S., Chen, Q., Noor, A., Knight, J., Hosang, G., et al. Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med. Genet., 15, 2014, 2.